<i>XPD</i> and <i>XRCC1</i> Genetic Polymorphisms Are Prognostic Factors in Advanced Non—Small-Cell Lung Cancer Patients Treated With Platinum Chemotherapy

2004294 citationsJournal Articlebronze Open Access

Authors

Genetic polymorphisms in XPD and XRCC1 may be important prognostic factors in platinum-treated patients with advanced NSCLC.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 22, Issue 13, pp. 2594-2601

Field-Weighted Citation Impact: 8.40